[27] Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors
- 1 January 2002
- book chapter
- Published by Elsevier BV in Methods in enzymology
- Vol. 346, 466-500
- https://doi.org/10.1016/s0076-6879(02)46072-7
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Production of EIAV based lentiviral vectors for gene therapyEuropean Journal Of Cancer, 2001
- Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral VectorsMolecular Therapy, 2001
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000
- Brief Report: Analysis of 4070A Envelope Levels in Retroviral Preparations and Effect on Target Cell Transduction EfficiencyHuman Gene Therapy, 2000
- Development of a Novel Trans-Lentiviral Vector That Affords Predictable SafetyMolecular Therapy, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Cell-Surface Marking of CD34+-Restricted Phenotypes of Human Hematopoietic Progenitor Cells by Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1997
- Conservation of amino-acid sequence motifs in lentivirus Vif proteinsVirus Genes, 1992
- Shedding and Interspecies Type Sero-reactivity of the Envelope Glycopolypeptide gp120 of the Human Immunodeficiency VirusJournal of General Virology, 1986